{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:49:19Z","timestamp":1792446559117,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-025-01061-3","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:03:12Z","timestamp":1770976992000},"page":"430-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Blood-based AT(N) biomarkers for Alzheimer\u2019s disease and frontotemporal lobar degeneration in Latin America"],"prefix":"10.1038","volume":"6","author":[{"given":"Ariel","family":"Caviedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Cabral-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Henr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-011X","authenticated-orcid":false,"given":"Raul","family":"Gonzalez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Migeot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ochoa-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gonzalez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickole","family":"Marin-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Coronel-Oliveros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"Santamar\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-0114","authenticated-orcid":false,"given":"Adolfo M.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Slachevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-8710","authenticated-orcid":false,"given":"Andy Yue","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dhooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pantazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu T.","family":"Udeh-Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-536X","authenticated-orcid":false,"given":"David","family":"Aguill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Matallana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo R.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa de Paula Fran\u00e7a","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-4368","authenticated-orcid":false,"given":"Francesca R.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-1484","authenticated-orcid":false,"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alberto","family":"Avila-Funes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Acosta-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Possin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3224-5179","authenticated-orcid":false,"given":"Kenneth S.","family":"Kosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-3132","authenticated-orcid":false,"given":"Kun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel T.","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Okada","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Adrian","family":"Maito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-426X","authenticated-orcid":false,"given":"Maria Isabel","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-3699","authenticated-orcid":false,"given":"Marta","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3925-1451","authenticated-orcid":false,"given":"Nancy","family":"Gelvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pozo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-5504","authenticated-orcid":false,"given":"J. Nicholas","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-3272","authenticated-orcid":false,"given":"Nilton","family":"Custodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9643-2091","authenticated-orcid":false,"given":"Rodrigo","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-4468","authenticated-orcid":false,"given":"Rodrigo","family":"Santibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0056-1361","authenticated-orcid":false,"given":"Sara","family":"Bandres-Ciga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Javandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M. D.","family":"Brucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7467-8365","authenticated-orcid":false,"given":"Stefanie D.","family":"Pina-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Valcour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-2634","authenticated-orcid":false,"given":"Jennifer S.","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6758-5101","authenticated-orcid":false,"given":"Agustin","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Duran-Aniotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Paula Fran\u00e7a Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Okada","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","volume":"28","author":"MM Mielke","year":"2022","unstructured":"Mielke, M. M. et al. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat. Med. 28, 1398\u20131405 (2022).","journal-title":"Nat. Med."},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"NR Barthelemy","year":"2024","unstructured":"Barthelemy, N. R. et al. Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests. Nat. Med. 30, 1085\u20131095 (2024).","journal-title":"Nat. Med."},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"S Palmqvist","year":"2024","unstructured":"Palmqvist, S. et al. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA 332, 1245\u20131257 (2024).","journal-title":"JAMA"},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954\u2013963 (2021).","journal-title":"Nat. Med."},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s43587-024-00656-6","volume":"4","author":"A Ibanez","year":"2024","unstructured":"Ibanez, A. Latin American brain-health research requires regional data and tailored models. Nat. Aging 4, 1041\u20131042 (2024).","journal-title":"Nat. Aging"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41582-024-00998-0","volume":"20","author":"A Ibanez","year":"2024","unstructured":"Ibanez, A. & Slachevsky, A. Environmental\u2212genetic interactions in ageing and dementia across Latin America. Nat. Rev. Neurol. 20, 571\u2013572 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"100616","DOI":"10.1016\/S2666-7568(24)00132-6","volume":"5","author":"E McGlinchey","year":"2024","unstructured":"McGlinchey, E. et al. Biomarkers of neurodegeneration across the Global South. Lancet Healthy Longev. 5, 100616 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","volume":"111","author":"H Hampel","year":"2023","unstructured":"Hampel, H. et al. Blood-based biomarkers for Alzheimer\u2019s disease: current state and future use in a transformed global healthcare landscape. Neuron 111, 2781\u20132799 (2023).","journal-title":"Neuron"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"101703","DOI":"10.1016\/j.arr.2022.101703","volume":"81","author":"F Ribeiro","year":"2022","unstructured":"Ribeiro, F., Teixeira-Santos, A. C., Caramelli, P. & Leist, A. K. Prevalence of dementia in Latin America and Caribbean countries: systematic review and meta-analyses exploring age, sex, rurality, and education as possible determinants. Ageing Res. Rev. 81, 101703 (2022).","journal-title":"Ageing Res. Rev."},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1017\/S1041610209009430","volume":"21","author":"R Nitrini","year":"2009","unstructured":"Nitrini, R. et al. Prevalence of dementia in Latin America: a collaborative study of population-based cohorts. Int. Psychogeriatr. 21, 622\u2013630 (2009).","journal-title":"Int. Psychogeriatr."},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/s41591-023-02495-1","volume":"29","author":"H Santamaria-Garcia","year":"2023","unstructured":"Santamaria-Garcia, H. et al. Factors associated with healthy aging in Latin American populations. Nat. Med. 29, 2248\u20132258 (2023).","journal-title":"Nat. Med."},{"key":"1061_CR12","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1038\/s41591-024-03209-x","volume":"30","author":"S Moguilner","year":"2024","unstructured":"Moguilner, S. et al. Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations. Nat. Med. 30, 3646\u20133657 (2024).","journal-title":"Nat. Med."},{"key":"1061_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63277-6","volume":"16","author":"J Migeot","year":"2025","unstructured":"Migeot, J. et al. Social exposome and brain health outcomes of dementia across Latin America. Nat. Commun. 16, 8196 (2025).","journal-title":"Nat. Commun."},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1038\/s41591-025-03808-2","volume":"31","author":"H Hernandez","year":"2025","unstructured":"Hernandez, H. et al. The exposome of healthy and accelerated aging across 40 countries. Nat. Med. 31, 3089\u20133100 (2025).","journal-title":"Nat. Med."},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.neuron.2024.04.016","volume":"112","author":"A Ibanez","year":"2024","unstructured":"Ibanez, A. et al. Neuroecological links of the exposome and One Health. Neuron 112, 1905\u20131910 (2024).","journal-title":"Neuron"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1212\/WNL.0000000000004897","volume":"90","author":"MA Parra","year":"2018","unstructured":"Parra, M. A. et al. Dementia in Latin America: assessing the present and envisioning the future. Neurology 90, 222\u2013231 (2018).","journal-title":"Neurology"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.3233\/JAD-201384","volume":"82","author":"A Ibanez","year":"2021","unstructured":"Ibanez, A., Parra, M. A., Butler, C. & Latin America and the Caribbean Consortium on Dementia (LAC-CD). The Latin America and the Caribbean Consortium on Dementia (LAC-CD): from networking to research to implementation science. J. Alzheimers Dis. 82, S379\u2013S394 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3233\/JAD-190924","volume":"73","author":"G Musa","year":"2020","unstructured":"Musa, G. et al. Alzheimer\u2019s disease or behavioral variant frontotemporal dementia? Review of key points toward an accurate clinical and neuropsychological diagnosis. J. Alzheimers Dis. 73, 833\u2013848 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat. Rev. Neurol. 17, 580\u2013589 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1061_CR20","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 21, 66\u201377 (2022).","journal-title":"Lancet Neurol."},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois, B. et al. Alzheimer disease as a clinical-biological construct-an international working group recommendation. JAMA Neurol. 81, 1304\u20131311 (2024).","journal-title":"JAMA Neurol."},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaneurol.2024.3766","volume":"81","author":"RC Petersen","year":"2024","unstructured":"Petersen, R. C., Mormino, E. & Schneider, J. A. Alzheimer disease\u2014what\u2019s in a name? JAMA Neurol. 81, 1245\u20131246 (2024).","journal-title":"JAMA Neurol."},{"key":"1061_CR24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande, G. et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat. Med. 31, 2027\u20132035 (2025).","journal-title":"Nat. Med."},{"key":"1061_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze, S. et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat. Med. 26, 379\u2013386 (2020).","journal-title":"Nat. Med."},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee, P. et al. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 19, 1117\u20131134 (2023).","journal-title":"Alzheimers Dement."},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton, N. J. et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat. Med. 28, 2555\u20132562 (2022).","journal-title":"Nat. Med."},{"key":"1061_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42596-6","volume":"14","author":"H Cai","year":"2023","unstructured":"Cai, H., Pang, Y., Fu, X., Ren, Z. & Jia, L. Plasma biomarkers predict Alzheimer\u2019s disease before clinical onset in Chinese cohorts. Nat. Commun. 14, 6747 (2023).","journal-title":"Nat. Commun."},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","volume":"81","author":"S Janelidze","year":"2024","unstructured":"Janelidze, S. et al. Plasma phosphorylated tau 217 and A\u03b242\/40 to predict early brain A\u03b2 accumulation in people without cognitive impairment. JAMA Neurol. 81, 947\u2013957 (2024).","journal-title":"JAMA Neurol."},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","volume":"5","author":"R Ossenkoppele","year":"2025","unstructured":"Ossenkoppele, R. et al. Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials. Nat. Aging 5, 883\u2013896 (2025).","journal-title":"Nat. Aging"},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/diagnostics13030332","volume":"13","author":"VC Constantinides","year":"2023","unstructured":"Constantinides, V. C. et al. Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics (Basel) 13, 332 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"e14482","DOI":"10.1002\/alz.14482","volume":"21","author":"A Benussi","year":"2025","unstructured":"Benussi, A. et al. Plasma p-tau(217) and neurofilament\/p-tau(217) ratio in differentiating Alzheimer\u2019s disease from syndromes associated with frontotemporal lobar degeneration. Alzheimers Dement. 21, e14482 (2025).","journal-title":"Alzheimers Dement."},{"key":"1061_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamaneurol.2023.0488","volume":"80","author":"L VandeVrede","year":"2023","unstructured":"VandeVrede, L. et al. Evaluation of plasma phosphorylated tau217 for differentiation between Alzheimer disease and frontotemporal lobar degeneration subtypes among patients with corticobasal syndrome. JAMA Neurol. 80, 495\u2013505 (2023).","journal-title":"JAMA Neurol."},{"key":"1061_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Thijssen, E. H. et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat. Med. 26, 387\u2013397 (2020).","journal-title":"Nat. Med."},{"key":"1061_CR36","doi-asserted-by":"publisher","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","volume":"91","author":"P Steinacker","year":"2018","unstructured":"Steinacker, P. et al. Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology 91, e1390\u2013e1401 (2018).","journal-title":"Neurology"},{"key":"1061_CR37","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/brain\/awaa165","volume":"143","author":"KAQ Cousins","year":"2020","unstructured":"Cousins, K. A. Q. et al. ATN status in amnestic and non-amnestic Alzheimer\u2019s disease and frontotemporal lobar degeneration. Brain 143, 2295\u20132311 (2020).","journal-title":"Brain"},{"key":"1061_CR38","first-page":"e12267","volume":"14","author":"SE O\u2019Bryant","year":"2022","unstructured":"O\u2019Bryant, S. E. et al. Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non-Hispanic whites: a Health & Aging Brain among Latino Elders (HABLE) study. Alzheimers Dement. 14, e12267 (2022).","journal-title":"Alzheimers Dement."},{"key":"1061_CR39","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3233\/JAD-210543","volume":"86","author":"SE O\u2019Bryant","year":"2022","unstructured":"O\u2019Bryant, S. E. et al. Proteomic profiles of neurodegeneration among Mexican Americans and non-Hispanic whites in the HABS-HD study. J. Alzheimers Dis. 86, 1243\u20131254 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1061_CR40","doi-asserted-by":"publisher","first-page":"e238214","DOI":"10.1001\/jamanetworkopen.2023.8214","volume":"6","author":"LS Honig","year":"2023","unstructured":"Honig, L. S. et al. Evaluation of plasma biomarkers for A\/T\/N classification of Alzheimer disease among adults of Caribbean Hispanic ethnicity. JAMA Netw. Open 6, e238214 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1061_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-024-01655-w","volume":"17","author":"N Pandey","year":"2025","unstructured":"Pandey, N. et al. Plasma phospho-tau217 as a predictive biomarker for Alzheimer\u2019s disease in a large south American cohort. Alzheimers Res. Ther. 17, 1 (2025).","journal-title":"Alzheimers Res. Ther."},{"key":"1061_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56756-3","volume":"16","author":"LE Santos","year":"2025","unstructured":"Santos, L. E. et al. Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort. Nat. Commun. 16, 2911 (2025).","journal-title":"Nat. Commun."},{"key":"1061_CR43","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1038\/s41380-025-03192-w","volume":"30","author":"WV Borelli","year":"2025","unstructured":"Borelli, W. V. et al. Diagnostic performance of Alzheimer\u2019s disease blood and CSF biomarkers in a Brazilian cohort with low educational attainment. Mol. Psychiatry 30, 6090\u20136098 (2025).","journal-title":"Mol. Psychiatry"},{"key":"1061_CR44","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","volume":"31","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist, S. et al. Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform. Nat. Med. 31, 2036\u20132043 (2025).","journal-title":"Nat. Med."},{"key":"1061_CR45","doi-asserted-by":"publisher","first-page":"631722","DOI":"10.3389\/fneur.2021.631722","volume":"12","author":"A Ibanez","year":"2021","unstructured":"Ibanez, A. et al. The Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat): driving multicentric research and implementation science. Front. Neurol. 12, 631722 (2021).","journal-title":"Front. Neurol."},{"key":"1061_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss, R., Faraggi, D. & Reiser, B. Estimation of the Youden Index and its associated cutoff point. Biom. J. 47, 458\u2013472 (2005).","journal-title":"Biom. J."},{"key":"1061_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14283\/jpad.2023.100","volume":"11","author":"Y Salimi","year":"2024","unstructured":"Salimi, Y., Domingo-Fernandez, D., Hofmann-Apitius, M. & Birkenbihl, C. Data-driven thresholding statistically biases ATN profiling across cohort datasets. J. Prev. Alzheimers Dis. 11, 185\u2013195 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1061_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13195-024-01647-w","volume":"16","author":"P Mohaupt","year":"2024","unstructured":"Mohaupt, P. et al. Blood-based biomarkers and plasma A\u03b2 assays in the differential diagnosis of Alzheimer\u2019s disease and behavioral-variant frontotemporal dementia. Alzheimers Res. Ther. 16, 279 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"1061_CR49","doi-asserted-by":"publisher","first-page":"e11170","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist, S. et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol. Med. 11, e11170 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1061_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1061_CR51","doi-asserted-by":"crossref","unstructured":"Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K. & Alzheimer\u2019s Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 74, 557\u2013566 (2017).","DOI":"10.1001\/jamaneurol.2016.6117"},{"key":"1061_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.31083\/j.jin2204085","volume":"22","author":"Z Fan","year":"2023","unstructured":"Fan, Z., Liu, X., Liu, J., Chen, C. & Zhou, M. Neurofilament light chain as a potential biomarker in plasma for Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and a meta-analysis. J. Integr. Neurosci. 22, 85 (2023).","journal-title":"J. Integr. Neurosci."},{"key":"1061_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","volume":"9","author":"M Grossman","year":"2023","unstructured":"Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Primers 9, 40 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1061_CR54","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms24021226","volume":"24","author":"L Alvarez-Sanchez","year":"2023","unstructured":"Alvarez-Sanchez, L. et al. Assessment of plasma and cerebrospinal fluid biomarkers in different stages of Alzheimer\u2019s disease and frontotemporal dementia. Int. J. Mol. Sci. 24, 1226 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1061_CR55","doi-asserted-by":"publisher","first-page":"118784","DOI":"10.1016\/j.cca.2024.118784","volume":"558","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: a multicenter cohort study. Clin. Chim. Acta 558, 118784 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"1061_CR56","first-page":"e12285","volume":"14","author":"EH Thijssen","year":"2022","unstructured":"Thijssen, E. H. et al. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Alzheimers Dement. 14, e12285 (2022).","journal-title":"Alzheimers Dement."},{"key":"1061_CR57","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/j.xcrm.2022.100607","volume":"3","author":"TF Gendron","year":"2022","unstructured":"Gendron, T. F. et al. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep. Med. 3, 100607 (2022).","journal-title":"Cell Rep. Med."},{"key":"1061_CR58","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaneurol.2025.0142","volume":"82","author":"V Bouteloup","year":"2025","unstructured":"Bouteloup, V. et al. Cognitive phenotyping and interpretation of Alzheimer blood biomarkers. JAMA Neurol. 82, 506\u2013515 (2025).","journal-title":"JAMA Neurol."},{"key":"1061_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/alz.12757","volume":"19","author":"MA Parra","year":"2023","unstructured":"Parra, M. A. et al. Biomarkers for dementia in Latin American countries: gaps and opportunities. Alzheimers Dement. 19, 721\u2013735 (2023).","journal-title":"Alzheimers Dement."},{"key":"1061_CR60","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"1061_CR61","first-page":"100387","volume":"17","author":"MA Maito","year":"2023","unstructured":"Maito, M. A. et al. Classification of Alzheimer\u2019s disease and frontotemporal dementia using routine clinical and cognitive measures across multicentric underrepresented samples: a cross sectional observational study. Lancet Reg. Health Am. 17, 100387 (2023).","journal-title":"Lancet Reg. Health Am."},{"key":"1061_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"1061_CR63","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"key":"1061_CR64","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006\u20131014 (2011).","journal-title":"Neurology"},{"key":"1061_CR65","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"1061_CR66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"1061_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong, M. J. et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 153\u2013174 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"1061_CR68","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant, S. E. et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s research consortium study. Arch. Neurol. 65, 1091\u20131095 (2008).","journal-title":"Arch. Neurol."},{"key":"1061_CR69","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jalz.2011.11.002","volume":"9","author":"JM Cedarbaum","year":"2013","unstructured":"Cedarbaum, J. M. et al. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer\u2019s disease clinical trials. Alzheimers Dement. 9, S45\u2013S55 (2013).","journal-title":"Alzheimers Dement."},{"key":"1061_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/alz.12033","volume":"16","author":"T Miyagawa","year":"2020","unstructured":"Miyagawa, T. et al. Utility of the global CDR\u00ae plus NACC FTLD rating and development of scoring rules: data from the ARTFL\/LEFFTDS Consortium. Alzheimers Dement. 16, 106\u2013117 (2020).","journal-title":"Alzheimers Dement."},{"key":"1061_CR71","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1002\/alz.14085","volume":"20","author":"R Gonzalez-Gomez","year":"2024","unstructured":"Gonzalez-Gomez, R. et al. Educational disparities in brain health and dementia across Latin America and the United States. Alzheimers Dement. 20, 5912\u20135925 (2024).","journal-title":"Alzheimers Dement."},{"key":"1061_CR72","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s43587-024-00781-2","volume":"5","author":"A Legaz","year":"2025","unstructured":"Legaz, A. et al. Structural inequality linked to brain volume and network dynamics in aging and dementia across the Americas. Nat. Aging 5, 259\u2013274 (2025).","journal-title":"Nat. Aging"},{"key":"1061_CR73","doi-asserted-by":"publisher","first-page":"103187","DOI":"10.1016\/j.eclinm.2025.103187","volume":"82","author":"R Gonzalez-Gomez","year":"2025","unstructured":"Gonzalez-Gomez, R. et al. Qualitative and quantitative educational disparities and brain signatures in healthy aging and dementia across global settings. EClinicalMedicine 82, 103187 (2025).","journal-title":"EClinicalMedicine"},{"key":"1061_CR74","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"1061_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-016-0176-z","volume":"8","author":"KR Chapman","year":"2016","unstructured":"Chapman, K. R. et al. Mini Mental State Examination and Logical Memory scores for entry into Alzheimer\u2019s disease trials. Alzheimers Res. Ther. 8, 9 (2016).","journal-title":"Alzheimers Res. Ther."},{"key":"1061_CR76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-025-01719-5","volume":"17","author":"F Martinez-Dubarbie","year":"2025","unstructured":"Martinez-Dubarbie, F. et al. Diagnostic performance of plasma p-tau217 in a memory clinic cohort using the Lumipulse automated platform. Alzheimers Res. Ther. 17, 68 (2025).","journal-title":"Alzheimers Res. Ther."},{"key":"1061_CR77","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/alz.12640","volume":"18","author":"MT Ashford","year":"2022","unstructured":"Ashford, M. T. et al. Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 18, 2603\u20132613 (2022).","journal-title":"Alzheimers Dement."},{"key":"1061_CR78","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1523\/JNEUROSCI.1312-22.2022","volume":"43","author":"J Cruzat","year":"2023","unstructured":"Cruzat, J. et al. Temporal irreversibility of large-scale brain dynamics in Alzheimer\u2019s disease. J. Neurosci. 43, 1643\u20131656 (2023).","journal-title":"J. Neurosci."},{"key":"1061_CR79","doi-asserted-by":"crossref","unstructured":"Nieto-Castanon, A. Handbook of Functional Connectivity Magnetic Resonance Imaging Methods in CONN (Hilbert Press, 2020).","DOI":"10.56441\/hilbertpress.2207.6598"},{"key":"1061_CR80","doi-asserted-by":"publisher","first-page":"e83970","DOI":"10.7554\/eLife.83970","volume":"12","author":"Y Sanz Perl","year":"2023","unstructured":"Sanz Perl, Y. et al. Model-based whole-brain perturbational landscape of neurodegenerative diseases. eLife 12, e83970 (2023).","journal-title":"eLife"},{"key":"1061_CR81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social,behavioral, and biomedical sciences. Behav. Res. Methods 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods"},{"key":"1061_CR82","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1037\/1082-989X.8.4.448","volume":"8","author":"J Sanchez-Meca","year":"2003","unstructured":"Sanchez-Meca, J., Marin-Martinez, F. & Chacon-Moscoso, S. Effect-size indices for dichotomized outcomes in meta-analysis. Psychol. Methods 8, 448\u2013467 (2003).","journal-title":"Psychol. Methods"},{"key":"1061_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1037\/1082-989X.13.1.19","volume":"13","author":"J Ruscio","year":"2008","unstructured":"Ruscio, J. A probability-based measure of effect size: robustness to base rates and other factors. Psychol. Methods 13, 19\u201330 (2008).","journal-title":"Psychol. Methods"},{"key":"1061_CR84","doi-asserted-by":"publisher","first-page":"120636","DOI":"10.1016\/j.neuroimage.2024.120636","volume":"295","author":"H Hernandez","year":"2024","unstructured":"Hernandez, H. et al. Brain health in diverse settings: how age, demographics and cognition shape brain function. Neuroimage 295, 120636 (2024).","journal-title":"Neuroimage"},{"key":"1061_CR85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium.","year":"2015","unstructured":"1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"1061_CR86","first-page":"e12008","volume":"12","author":"AM Kulminski","year":"2020","unstructured":"Kulminski, A. M. et al. Genetic and regulatory architecture of Alzheimer\u2019s disease in the APOE region. Alzheimers Dement. 12, e12008 (2020).","journal-title":"Alzheimers Dement."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-01061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-01061-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-01061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:05:01Z","timestamp":1771513501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-01061-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-01061-3","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Z. has served on scientific advisory boards and\/or as a consultant for AbbVie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk and Roche; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). Not related to the current work, K.H. is the Honorary Lifetime Co-founder of iFutureLab Inc., serves on the scientific advisory board of the company and has received consulting fees from the company. Z.L.\u2019s participation in this project was part of a competitive contract awarded to DataTecnica LLC by the NIH to support open science research. S.M.D.B. has served on scientific advisory boards and\/or as a consultant for Biogen, Lilly, Novo Nordisk and Roche and has received a research productivity grant from the National Council for Scientific and Technological Development (Ministry of Science and Technology\u2212Brazil). M.S.-C. has received consultancy\/speaker fees (paid to the institution) in the past 36\u2009months from Almirall, Lilly, Quanterix, Novo Nordisk and Roche Diagnostics. He has received consultancy fees from or served on advisory boards (paid to the institution) of Lilly, Grifols, Novo Nordisk and Roche Diagnostics. He was granted a project and is a site investigator of a clinical trial (funded to the institution) by Roche Diagnostics. In-kind support for research (to the institution) was received from ADx Neurosciences, Alamar Biosciences, ALZpath, Avid Radiopharmaceuticals, Lilly, Fujirebio, Janssen Research & Development, Meso Scale Discovery and Roche Diagnostics. M.S.-C. did not receive any personal compensation from these organizations or any other for-profit organization. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}